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SUMMARY
The classical model of hematopoiesis established in the mouse postulates that lymphoid cells originate from a founder population of common lymphoid progenitors. Here, using a modeling approach in humanized mice, we showed that human lymphoid development stemmed from distinct populations of CD127 À and CD127 + early lymphoid progenitors (ELPs). Combining molecular analyses with in vitro and in vivo functional assays, we demonstrated that CD127 À and CD127 + ELPs emerged independently from lympho-mono-dendritic progenitors, responded differently to Notch1 signals, underwent divergent modes of lineage restriction, and displayed both common and specific differentiation potentials. Whereas CD127
À ELPs comprised precursors of T cells, marginal zone B cells, and natural killer (NK) and innate lymphoid cells (ILCs), CD127 + ELPs supported production of all NK cell, ILC, and B cell populations but lacked T potential. On the basis of these results, we propose a ''two-family'' model of human lymphoid development that differs from the prevailing model of hematopoiesis.
INTRODUCTION
According to the standard model established in the mouse, the hematopoietic system displays a branched structure organized as a series of dichotomous cell hierarchies and development intermediates with gradually restricted growth and differentiation potentials. Hematopoietic stem cells (HSCs) are assumed to give rise to lineage-biased multipotent progenitors (MPPs) segregating into common myeloid progenitors (CMPs) (Akashi et al., 2000) and common lymphoid progenitors (CLPs) (Kondo et al., 1997) . CLPs define a founder population undergoing further diversification into early B cell precursors (EBPs), and natural killer and innate lymphoid cell precursors (NKIPs), which continue to differentiate locally, or into early T cell precursors (ETPs) leaving the bone marrow (BM) for the thymus. Recently, substantial progress has been made in characterizing MPPs, which segregate into populations oriented toward the erythromegakaryocyte, granulocyte-macrophage, or lymphoid lineages, the latter being referred to as lymphoid-primed multipotent progenitors (LMPPs) (Pietras et al., 2015) . As they progress along the lymphoid lineage, LMPPs lose myeloid potential to differentiate into lymphoid-restricted CLPs (Adolfsson et al., 2005; Mansson et al., 2007) including multi-lymphoid as well as T, B, and NK-ILC lineage-biased progenitors (Berthault et al., 2017; Ramond et al., 2014) .
Whether human hematopoiesis follows the same development scheme as in the mouse remains uncertain (Doulatov et al., (legend on next page) 2012). Reports from the last three decades have established that acquisition of CD45RA marks a key developmental transition in human hematopoietic development (Fritsch et al., 1993) . Whereas the CD38 À/lo CD45RA À compartment comprises HSCs, MPPs, and megakaryocyte-erythroid progenitors (Notta et al., 2011; Notta et al., 2015) , monocyte and dendritic cell (DC) lineages co-segregate with the lymphoid fate in the CD38 lo/+ CD45RA + hematopoietic progenitor cell (HPC) population. CD7 (Canque et al., 2000; Hao et al., 2001 ), CD10 (Doulatov et al., 2010; Galy et al., 1995) , or CD62L (Kohn et al., 2012) are commonly used to identify CD45RA + HPC populations enriched in lymphoid potential, but because none of these are lymphoidrestricted, their value as lineage-defining markers remains contentious. Thus, whether human lymphopoiesis is initiated by a founder population orthologous to murine CLPs is still unclear.
To address these issues, we developed a modeling approach in humanized mice (Parietti et al., 2012) . Combining optimized immuno-phenotypic stratification of CD34 hi CD45RA
+ HPCs with molecular and functional characterization of more than 30 cell populations, we show that human lymphoid development stemmed from functionally specialized subsets of CD127 À and CD127 + early lymphoid progenitors (ELPs), and
propose an updated ''two-family'' model of human lymphoid development.
RESULTS

Modeling Fetal Hematopoiesis in Humanized NOD-scidIL2Rg null (NSG) Mice
We have previously shown that NSG mice engrafted with umbilical cord blood (UCB) CD34 + HPCs (referred to as NSG-UCB mice hereafter) transiently support production of a BM CD34 + CD7 + cell population reminiscent of human fetal thymus-colonizing cells (Parietti et al., 2012) . Here, we analyzed NSG-UCB mice for 2 to 8 weeks and showed that CD34 + CD7 + cells peaked by day 21, which was then defined as the reference time-point for subsequent analyses (Figures S1A-S1C). Comparable engraftment efficiencies and phenotypes were noted in mice grafted with fetal or neonatal HPCs, which contrasted with < 2% chimerism in recipient mice of adult CD34 + HPCs (data not shown). To determine how the xenogeneic setting compared with primary hematopoiesis, we analyzed CD45 + BM cells from fetal (13 to 29 gestation weeks) and postnatal (13 to 55 years old) donors by multi-parameter flow cytometry. As reported (Haddad et al., 2006) , CD34 + CD7 + cell percentages reached maximum levels during gestation trimester two at which time the phenotypic profile of BM cells closely matched that of day-21 NSG-UCB mice (Figures S1D and S1E) . Analysis by high-resolution fluorescence scanning of femurs from NSG-UCB mice showed that human (hu-) CD45 + cells distributed unevenly in dense foci scattered throughout the trabecular bone area ( Figure S1F ) which suggests that, for the first 3 weeks after grafting, xenogeneic hematopoiesis proceeds in a fully humanized environment driven by founder effects. These data indicate that, at week-3 post grafting with fetal or neonatal CD34 + HPCs, the BM of NSG-UCB mice supported a multi-lineage human hematopoiesis reminiscent of the mid-fetal period. (Doulatov et al., 2010) showed LMDPs' high cloning efficiency with a majority of mixed B-Monocyte-NK (B-M-NK) or B-M clones ( Figures 3E-3G To determine whether CD127 À CD7 + ELPs (F6) comprised bipotent T and NK-ILC precursors or a mix of ETPs and NKIPs, we further partitioned these based on CD7 and CD2 expression into three F6a, F6b, and F6c subsets ( Figure 4A Figure S3A . HSCs-MPPs, hematopoietic stem cell-multipotent progenitor; Gr, granulocyte progenitor; LMDP, lympho-mono-dendritic cell progenitor; MLP, multilymphoid progenitors; EBP, early B cell precursor; NKIP, NK-ILC precursor; MDCP, monocyte-DC progenitor.
(C) Gene-expression profiling of the CD34 hi HPCs. Hierarchical clustering is based on the expression of 56 genes. Pools of 50 cells were sorted and analyzed as above by multiplex RT-PCR. Gene expression levels are normalized relative to HPRT. The black arrows indicate CD127. Colored squares and lineage-specific fingerprints are defined as in Figure 1D and Figure 5I ). Clonal assays led also to similar percentages of NK-and ILC1-containing clones in CD127 À and CD127 + NKIPs ( Figure 5J , left and medium panels), and showed the expected enrichment of CD127 + NKIPs in ILC3 precursors (40% versus 27%; p = 0.04, c 2 test) ( Figure 5J , right panel).
Molecular characterization of in vitro-generated NK cells, ILC1s and ILC3s found the expected gene signatures, with substantial differences according to whether cells originated from CD127 À or CD127 + NKIPs ( Figure 5K ). CD127 À NKIP-derived NK cells had higher expression of IFNG, GZMB and GZMK transcripts, while ILC3s differentiated from CD127 + NKIPs retained a B lineage trait (VPREB1, CD79B, IGK). Phenotypic analysis based on 35 NK-ILC surface markers, and assessment of activation-induced degranulation and LTi activity, failed to show differences between homologous cell subsets originating from CD127 À or CD127 + NKIPs ( Figure 5L , and data not shown). Cytokine production assays found that CD56 + CD94 + NK cells differentiated from CD127 À NKIPs produced higher interferon (IFN)-g and tumor necrosis factor (TNF)-a levels than those issued from CD127 + NKIPs ( Figure 5M ). Irrespective of their origin, ILC3s produced overall similar IL17A levels. ILC2-specific cytokines (IL-5, IL-13), as well as IL-22 and lymphotoxin (LT)-b, were undetectable in culture supernatants (data not shown). Figure S4A ). Maintaining LMDPs for a longer period of culture (7 days) increased the myeloid output without affecting ELP differentiation ( Figure S4B , upper panel). Adding SCF increased total cell yields > 3-fold without interfering with ELP differentiation ( Figure S4B Whether inhibition of IL-7R signaling affected the emergence of CD127 À and CD127 + ELPs was next examined, but treating NSG-UCB mice with JAK3 inhibitor, CP-690550, did not affect lymphoid development (data not shown). To investigate the possible involvement of Notch signaling in this process, we grafted NSG mice with CD34 + HPCs transduced with lentiviral vectors driving expression of a Notch1-specific small hairpin RNA (shNotch1). As reported in the mouse (Radtke et al., 1999) , reducing Notch1 expression led to a profound inhibition of intrathymic development in NSG-UCB mice ( Figures S5A  and S5B ). At week 3 after grafting, Notch1 knockdown resulted in a 2-fold increase in the frequency of the most immature CD45RA
À HPCs, and CD38 upregulation was limited relative to controls ( Figure S5C ). ( Figure 7C ). Thymus colonization (R100 hu-CD45 + cells/thymus) and intra-thymic T cell development was noted in all positive mice engrafted with CD127 À ELPs, whereas only rare hu-CD45 + cells (< 10 hu-CD45 + cells/thymus) could be detected in the thymi of mice receiving LMDPs or CD127 + ELPs ( Figure 7D ). Thus, CD127 À and CD127 + ELPs differed as to the capacity to generate specific B and NK-ILCs subsets, and to ensure thymus colonization in vivo. Figure S3A for the complete gating procedure.
(legend continued on next page)
NSG-UCB from steady-state fetal hematopoiesis ( Figures  S6A-S6C ). High-throughput gene set enrichment analyses (GSEA) and cross-dataset enrichment analysis (Spinelli et al., 2015) using cell subset-specific gene signatures revealed the correspondence between phenotypically identical NSG-UCB and primary populations, albeit with limited overlap for CD127 À CD7 À MLPs (Table S3 and Figures S6D-S6F ). These data indicate that, during the first 3 weeks after grafting, the xenogeneic setting did not introduce major distortions in the transcription profile of human LMDPs and ELPs. LMDPs were then used as reference to generate consensus relative signatures shared by homologous NSG-UCB and primary ELP subsets (Table S4 ). Direct comparison of CD127 À
CD7
À and CD7 + ELPs found the expected segregation of T and NK-ILC lineage genes in the latters and disclosed a more composite gene expression pattern in their multilymphoid counterparts (Figures S6G and S6H; and Figure 7G ). These results indicate that, despite divergent lymphoid architectures, the gene regulatory networks governing lymphoid specification have been conserved from mice to humans.
DISCUSSION
Here, we provide a roadmap of human lymphopoiesis that supports a ''two-family'' model of lymphoid development ( Figure 7H) . A sorting scheme of CD34 hi CD45RA + HPCs, which resolves monocytic-DC and lymphoid lineages, identified two founder populations of CD127 À and CD127 + ELPs originating from multipotent LMDP intermediates. Although LMDPs were functionally and phenotypically close to previously reported human MLPs (Doulatov et al., 2010) or murine LMPPs (Adolfsson et al., 2005) , our results do not support the idea that this population was already lymphoid primed. Instead, they indicate that lymphoid priming coincided with ITGB7 upregulation by LMDPs. Consistent with this view, LMDPs were poorly efficient at generating lymphoid cells in mono-lineage differentiation assays, but displayed high cloning efficiency and generated a majority of Notch1, IL-7, and IL-15 for optimal differentiation into ILC3s. In the same manner, CD127 À and CD127 + proB1s differed as to maturation patterns, MZ versus follicular B cell differentiation potential and dependence on IL-7. At the developmental level, we provide evidence that CD127 À and CD127 + ELPs emerged independently from LMDPs, underwent divergent modes of lineage restrictions and were subjected to differential Notch1 regulation. Whereas Notch1 drove the emergence of CD127 + CD7 + MLPs and prevented their subsequent B lineage diversion, within the CD127 À ELP compartment it primarily acted by promoting ETP differentiation. Our finding that ETPs display a CD127 À origin confirm our previous report that fetal thymus immigrants lack surface CD127, whose upregulation depends on intrathymic Notch signaling (Haddad et al., 2006) . Our results are also consistent with recent reports that CD127 À and CD127 + NKIPs are detected in human blood (Lim et al., 2017) , tonsils or the intestinal lamina propria (Bernink et al., 2015; Crellin et al., 2010) , but at variance with others claiming that NK cells and ILCs share a single common precursor (Renoux et al., 2015; Scoville et al., 2016) .
Finally, our results should contribute to a better understanding of the molecular and cellular basis of inherited immune diseases affecting the lymphoid lineage, and help to identify the cells of origin of lymphoid malignancies.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Bruno Canque (bruno.canque@ephe.sorbonne.fr).
EXPERIMENTAL MODEL AND SUBJECT DETAILS Human Sample Collection
Human fetal (gestational ages 13 to 29 weeks, n = 21) or adult (13-55 years, n = 7) tissues from male or female donors were collected after informed consent according to institutional guidelines and the French bioethical legislation. Umbilical cord blood (UCB) was provided by the Unité de Thé rapie Cellulaire of Hô pital Saint-Louis (Paris). Adult bone marrow (BM) samples were from healthy graft donors (Unité de Thé rapie Cellulaire, Hô pital Saint-Louis, Paris). Fetal BMs were from spontaneously terminated pregnancies (Service de Biologie du Dé veloppement, Hô pital Robert Debré , Paris).
MICE
NOD.Cg-Prkdc scid IL2RG tm1wjl /SzJ (005557) mice known as NOD scid gamma (NSG) mice (Jackson Laboratory, Bar Harbor, MI) were housed in the pathogen-free animal facility of Institut Universitaire d'Hé matologie (Paris). Male or female NSG mice (n > 400) were xenografted at 2 months of age. The Ethical Committee at Paris Nord University approved all performed experiments.
METHODS DETAILS Processing of Human Tissues and Cell Separation
Femurs from fetal donors were sterilely excised and processed in RPMI 1640 medium supplemented with 10 U/ml RNase-free DNase I, before single-cell suspensions were filtered through a cell strainer (70 mm; BD biosciences). Blood or BM mononuclear cells were separated by Ficoll-Hypaque centrifugation (Pancoll, PAN Biotech GmbH) before processing for flow cytometry, cell sorting or CD34 + HPC isolation. CD34 + HPCs were isolated with the CD34 Microbead kit (Miltenyi Biotech; purity > 90%), frozen in heat-inactivated fetal calf serum (FCS) supplemented with 10% DMSO, and stored in liquid nitrogen until use. Single-cell suspensions recovered from femurs and tibias were filtered through a cell strainer (70 mm; BD biosciences) and depleted in mouse cells using the Mouse Cell Depletion Kit (Miltenyi) before being processed for Flow Cytometry or cell sorting. For secondary transfer experiments, 3-5 3 10 4 (CD127 -ELPs, LMDPs) to 2 3 10 5 (CD127 + ELPs) cells sorted from the BM of NSG-UCB mice were injected in the facial vein of sublethally irradiated newborn recipients together with 0.2 mg of SCF, IL-2 and IL-7 (all from Miltenyi Biotech). Mice received SCF, IL-2 and IL7 (0.2 mg each) by intraperitoneal injection weekly and were analyzed four weeks post-transplantation. Recipient mice were considered as positive for cell engraftment when hu-CD45 + cells constituted R 0.01% of total BM mononuclear cells.
Flow Cytometry and Cell Sorting
Single-cell suspensions were incubated with human Fc receptor-binding inhibitor (Fc Block, eBioscience) before surface staining with anti-human monoclonal antibodies (mAbs). Fluorescence minus one (FMO) controls with isotype controls were used to define positive signals for flow cytometry or cell sorting. Dead cells were excluded with the Zombie Violet Fixable Viability Kit (Biolegend). For labeling, cells were resuspended in PBS, 2% FCS (1 to 5 x10 7 cells/500 ml) and incubated with the following mAbs: CD45 A700
Lentiviral Vectors
The PRRL lentiviral backbone was kindly provided by Hana Raslova (Institut Gustave Roussy, France). Knockdown experiments were performed by using the PRRL-EF1a/EGFP vector with H1 driving hairpin expression. shNotch1 (GGAGCATGTGTAACAT CAACA), shNotch2 (GCAGAGGACTCTTCTGCTAAC) have been described previously (Delaney et al., 2005) . shNotch1 and shNotch2 knockdown vectors reduce Notch1/2 levels by R 80% in UCB CD34 + HPCs (data not shown). UCB CD34 + cells (purity > 90%) were transduced 6-8 hours at a multiplicity of infection of 20-25 in RPMI medium supplemented with 20% BIT 9500 (StemCell Technologies) and SCF (50 ng/ml), FLT3L (50 ng/ml), TPO (20 ng/ml) and IL-3 (10 ng/ml; all from Milteynyi) before injection to irradiated mice.
Fluidigm Analyses
Gene expression analyses were performed with the Fluidigm 96.96 Dynamic Array IFC and TaqMan Gene Expression Assays (Life Technologies). Fifty cells were sorted directly into 96-well PCR plate containing 2.5 ml TaqMan specific gene assay mix (Applied Biosystems), 5 ml of CellsDirect 2x Reaction mix, 0,2 ml SuperScriptTM III RT/PlatinumR Taq Mix (Invitrogen, CellsDirect one-step qRT-PCR kit), 1.2 mL TE buffer, and 0.1 ml SUPERase-In RNase Inhibitor (Ambion). Reverse transcription was performed for 15 min at 50 C followed by 2 min at 95 C for RT inactivation. The corresponding cDNAs were then preamplified for 21 cycles at 95 C for 15 s and 60 C for 4 min. Preamplified products were diluted 1:5 in TE buffer and analyzed on a Biomark system (Fluidigm) with the following PCR cycling condition: 95 C for 10 min and 40 cycles at 95 C for 15 s and 60 C for 60 s. Data were analyzed using the Biomark qPCR analysis software (Fluidigm). For gene expression quantification, data were exported as an Excel file and analyzed by the DDCt method. Results were normalized to HPRT or GAPDH expression, and expressed as mean expression levels of 3 to 12 biological replicates. Hierarchical clustering was performed on standardized means of gene expression levels using the Euclidean or the Manhattan distance using the ''pheatmap'' R package. For single-cell analyses, cell were were sorted individually into 96-well PCR using the Index Sorting module of the FACSDiva V8.01 software and processed as above except that 29 cycles of pre-amplification were performed. Results are expressed as mean of 3-4 technical replicates and normalized relative to GAPDH expression. Hierarchical clustering was performed with the ''morpheus'' software (https://software.broadinstitute.org/morpheus/).
References of the TaqMan primers used for the analysis can be communicated on demand.
Processing of Microarray Data
For microarray analyses of human cells, 1 or 2 biological replicates (3-5000 cells/sample) were used for each population sorted from NSG-UCB or the BM of gestation week 21 fetal donor (GEO: GSE90924). Inasmuch as the analysis focuses on the earliest stages of lymphoid ontogeny, CD7 + CD2 + NKIPs were excluded from the gating procedure. Cell isolation, labeling and subsequent sorting were performed as described above in ''Flow cytometry and cell sorting.'' Cells were sorted in RLT Plus Buffer before total RNA purification using the RNeasy Plus Micro Kit (QIAGEN). RNAs quantification and quality controls were performed using the HT RNA Pico sensitivity LabChip Kit and the Caliper LabChip Microfluidic System (Perkin Elmer). For each sample 1 ng of total RNA was amplified, labeled, and fragmented using GenChip WT Pico (Affymetrix 
B220
-; GSM791131; GSM791132; GSM791133) were downloaded from the Immgen consortium (Immgen.org). The Mouse Gene 1.0 ST CEL files were processed through Bioconductor in the R statistical environment (version 3.0.2). Quality control of the array hybridization (NUSE plot) and normalization of the raw Affymetrix expression data with RMA (Irizarry et al., 2003) were performed using the Oligo package. Partial Least Square (PLS) correction was then performed to remove the data source effect. Based on the density plot of the normalized expression values, probes not reaching a minimal value of 6 (log2 scale) across all arrays were removed from the analysis.
QUANTIFICATION AND STATISTICAL ANALYSIS
Generation of Human Fingerprints
To decipher the development stage or lineage affiliation of the cell subsets subjected to Fluidigm analysis, we generated cell-type and/or cell-lineage specific fingerprints by analyzing the expression pattern of the genes of interest across public datasets downloaded from GEO (GSE72642, GSE28490, GSE78896, GSE42414, GSE74246) or from ArrayExpress (E-TABM-34), encompassing various cell populations from early progenitors to terminally differentiated cells. Each dataset was processed through Bioconductor in the R (version 3.3.2) statistical environment. Using the limma package, Affymetrix genechips and Illumina expression beadchips were pre-processed and normalized using the Robust Multi-chip Average (RMA) procedure and the quantile normalization method, respectively. Illumina RNA sequencing raw counts data were processed and RPKM values were obtained using the edgeR and annotate packages. Log2 expression values were then submitted to GeneSign (BubbleGUM) in order to extract the cell-specific and/or cell-lineage fingerprints, using the Min(test)/Max(ref)>1.2x method. Moreover, since the identity of a cell population and/or a cell lineage can rely not only on the expression of genes more highly expressed exclusively in that population and/or lineage as compared to other populations, but also on groups of genes that, when expressed together at high level, constitute the fingerprint of the population of interest, we developed a strategy to identify such groups of genes by merging all the data together in such a way that the expression of the genes were comparable, independently of whether they were assessed using gene chips or RNA sequencing. To do so, we focused on the projects that encompassed CD4 + T cell expression data (GSE72642 and E-TABM-34 normalized together with RMA, GSE28490, GSE78896, and GSE74246). We used this common reference population to scale the expression of the genes in each cell samples. For microarray data, for each single gene, only the probe having the highest expression across all arrays was kept in order to remove redundancy. We then merged the data from the different projects and performed a hierarchical clustering on both the samples and the genes in order to detect groups of genes highly expressed in specific groups of cell populations. The result of the analysis for fingerprint generation is summarized in Table S2 . The corresponding genes are referred to as ''Computationally defined genes'' (left column). Experimentally validated upstream regulators of hematopoietic development that did not fall in Mathematically defined fingerprints are referred to as ''Experimentally defined genes'' (right column).
Microarray Analysis and Bioinformatics
For principal component analysis of human transcriptome data, PCA of human transcriptome data was performed in R using the ade4 package. Probesets contributing the most to PCs 1 and 2 were selected as having loadings (correlation between a gene and a PC) above 0.5 or below À0.5 based on examination of the loading density plot for each PC. This allowed selection of 1216 probesets as drivers for PC1, and of 539 probesets for PC2. Ingenuity pathway analysis (IPA) was performed on these probesets.
The BubbleGUM software (Spinelli et al., 2015) was used to generate cell-specific transcriptomic signatures from a given dataset and to assess their enrichment across cell types from another dataset (http://www.ciml.univmrs.fr/applications/BubbleGUM/index. html). BubbleGUM is composed of two modules; i) GeneSign, which generates transcriptomic signatures and ii) BubbleMap, which automatically assesses the enrichment of input gene signatures between all possible pairs of conditions from independent datasets, based on gene set enrichment analysis (GSEA) methodology (Subramanian et al., 2007; Subramanian et al., 2005) . The output is an integrated graphical display. Using GeneSign, gene signatures of each population sorted from NSG-UCB or primary fetal BM were generated for each dataset, i.e., the lists of genes that are more highly expressed in the cell population of interest (test classes) as compared to other cell populations (reference classes). To do this, we used the ''Min(test)/Max(ref)>1x'' calculation method on the probes that consistently changed expression at least 2 folds across all cell populations of the NSG-UCB or FBM datasets. To run BubbleMap, we used these in-house signatures of cell populations devised in GeneSign as well as GeneSets randomly generated in order to increase statistical power. BubbleMap was run with 1000 geneset-based permutations, and with ''signal to noise'' as a metric for ranking the genes. The results are displayed as a BubbleMap, where each bubble is a GSEA result and summarizes the information from the corresponding enrichment plot. The color of the Bubble corresponds to the subset from the pairwise comparison in which the signature is enriched. The bubble area is proportional to the GSEA normalized enrichment score (NES). The intensity of the color corresponds to the statistical significance of the enrichment measured by the false discovery rate (FDR) derived by computing the multiple testing-adjusted permutation-based p value using the Benjamini-Yekutieli correction. ) relative to LMDPs from the NSG-UCB or the FBM dataset. Human cell specific relative signatures then consisted in the top 6000 probes having the highest fold changes according to this analytical approach. The same method was applied to murine HSA lo or HSA hi populations relative to MLPs for the generation of relative murine gene signatures.
For generation of consensus gene signatures, probes that were found in the intersection of the Venn diagram obtained by overlapping the equivalent relative signatures from the NSG-UCB and FBM datasets were then subjected to an extra filter that consisted in selecting only the probes that were consistently (in both NSG-UCB and FBM datasets) higher in a population of interest (ex: CD127 -CD7 -) as compared to another population of interest (ex: CD127 -CD7 + ) using the « Min(test)/Max(ref)>1x » calculation method, in order to extract the final consensual gene signature. Cross-dataset or cross-species transcriptomic comparisons were performed using BubbleMap with the settings defined above or using classical GSEA in the case of the family (CD127 -versus CD127 + and HSA lo versus HSA hi ) comparisons. In the case of the crossspecies comparisons, the symbols of the genes belonging to the relative species-specific gene signatures were converted into the gene symbols of the orthologous genes in the other species, using Ensembl Biomart, before application of BubbleMap or GSEA. In order to extract the final conserved family gene signatures, the leading edge of each GSEA analysis was extracted. Corresponding leading edges were pooled together to obtain the final CD127 + /HSA hi and CD127 -/HSA lo conserved gene signatures. Heatmaps were generated using Morpheus from the Broad Institute (https://software.broadinstitute.org/morpheus/). Data are represented as Median unless specified. The sample size for each experiment and the replicate number of experiments are included in the figure legends. For two-group comparisons p values are calculated with the unpaired Student't test or the Mann-Whitney test as applicable with Prism.
DATA AND SOFTWARE AVAILABILITY
Data Resources
The accession numbers for the microarray data reported in this paper are Gene Expression Omnibus (GEO): GSE90924 and GSE84366.
